Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Jafari N, Drury J, Morris AJ, Onono FO, Stevens PD, Gao T, Liu J, Wang C, Lee EY, Weiss HL, Evers BM, Zaytseva YY.

Mol Cancer Res. 2019 Jan;17(1):140-152. doi: 10.1158/1541-7786.MCR-18-0199. Epub 2018 Aug 28.

PMID:
30154249
2.

Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer.

Stevens PD, Wen YA, Xiong X, Zaytseva YY, Li AT, Wang C, Stevens AT, Farmer TN, Gan T, Weiss HL, Inagaki M, Marchetto S, Borg JP, Gao T.

Cancer Res. 2018 Sep 1;78(17):4839-4852. doi: 10.1158/0008-5472.CAN-17-3629. Epub 2018 Jul 6.

3.

PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.

Smith AJ, Wen YA, Stevens PD, Liu J, Wang C, Gao T.

Oncotarget. 2016 Feb 16;7(7):7801-15. doi: 10.18632/oncotarget.6848.

4.

The role of molecular analysis in the diagnosis and surveillance of pancreatic cystic neoplasms.

Winner M, Sethi A, Poneros JM, Stavropoulos SN, Francisco P, Lightdale CJ, Allendorf JD, Stevens PD, Gonda TA.

JOP. 2015 Mar 20;16(2):143-9. doi: 10.6092/1590-8577/2941.

5.

Interobserver agreement for evaluation of imaging with single operator choledochoscopy: what are we looking at?

Sethi A, Widmer J, Shah NL, Pleskow DK, Edmundowicz SA, Sejpal DV, Gress FG, Pop GH, Gaidhane M, Sauer BG, Stevens PD, Kahaleh M.

Dig Liver Dis. 2014 Jun;46(6):518-22. doi: 10.1016/j.dld.2014.02.004. Epub 2014 Mar 16.

PMID:
24646882
6.

PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.

Li X, Stevens PD, Liu J, Yang H, Wang W, Wang C, Zeng Z, Schmidt MD, Yang M, Lee EY, Gao T.

Gastroenterology. 2014 May;146(5):1301-12.e1-10. doi: 10.1053/j.gastro.2014.02.003. Epub 2014 Feb 11.

7.

Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells.

Wen YA, Stevens PD, Gasser ML, Andrei R, Gao T.

Mol Cell Biol. 2013 Nov;33(22):4594-605. doi: 10.1128/MCB.00695-13. Epub 2013 Sep 23.

8.

Evaluation of a fully covered self-expanding metal stent with flared ends in malignant biliary obstruction: a multicenter study.

Kahaleh M, Talreja JP, Loren DE, Kowalski TE, Poneros JM, Degaetani M, Raijman I, Sejpal DV, Patel S, Rosenkranz L, McNamara KN, Brijbassie A, Wang AY, Gaidhane M, Sethi A, Stevens PD.

J Clin Gastroenterol. 2013 Nov-Dec;47(10):e96-100. doi: 10.1097/MCG.0b013e3182951a32.

PMID:
23933803
9.

Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1).

Liu J, Stevens PD, Eshleman NE, Gao T.

J Biol Chem. 2013 Aug 9;288(32):23225-33. doi: 10.1074/jbc.M113.492371. Epub 2013 Jun 28.

10.

Multicenter trial evaluating the use of covered self-expanding metal stents in benign biliary strictures: time to revisit our therapeutic options?

Kahaleh M, Brijbassie A, Sethi A, Degaetani M, Poneros JM, Loren DE, Kowalski TE, Sejpal DV, Patel S, Rosenkranz L, McNamara KN, Raijman I, Talreja JP, Gaidhane M, Sauer BG, Stevens PD.

J Clin Gastroenterol. 2013 Sep;47(8):695-9. doi: 10.1097/MCG.0b013e31827fd311.

PMID:
23442836
11.

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.

Fine RL, Gulati AP, Krantz BA, Moss RA, Schreibman S, Tsushima DA, Mowatt KB, Dinnen RD, Mao Y, Stevens PD, Schrope B, Allendorf J, Lee JA, Sherman WH, Chabot JA.

Cancer Chemother Pharmacol. 2013 Mar;71(3):663-70. doi: 10.1007/s00280-012-2055-z. Epub 2013 Jan 31.

PMID:
23370660
12.

A multicenter, U.S. experience of single-balloon, double-balloon, and rotational overtube-assisted enteroscopy ERCP in patients with surgically altered pancreaticobiliary anatomy (with video).

Shah RJ, Smolkin M, Yen R, Ross A, Kozarek RA, Howell DA, Bakis G, Jonnalagadda SS, Al-Lehibi AA, Hardy A, Morgan DR, Sethi A, Stevens PD, Akerman PA, Thakkar SJ, Brauer BC.

Gastrointest Endosc. 2013 Apr;77(4):593-600. doi: 10.1016/j.gie.2012.10.015. Epub 2013 Jan 3.

PMID:
23290720
13.

Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.

Gulhati P, Zaytseva YY, Valentino JD, Stevens PD, Kim JT, Sasazuki T, Shirasawa S, Lee EY, Weiss HL, Dong J, Gao T, Evers BM.

Carcinogenesis. 2012 Sep;33(9):1782-90. doi: 10.1093/carcin/bgs203. Epub 2012 Jun 13.

14.

Endoscopic neogastrogastrostomy in a postgastric bypass patient by application of an endoscopic antegrade-retrograde rendezvous technique.

Iqbal S, Bessler M, Stevens PD, Sethi A.

Surg Obes Relat Dis. 2012 Sep-Oct;8(5):651-3. doi: 10.1016/j.soard.2012.03.010. Epub 2012 Apr 10. No abstract available.

PMID:
22578290
15.

The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.

Li X, Stevens PD, Yang H, Gulhati P, Wang W, Evers BM, Gao T.

Oncogene. 2013 Jan 24;32(4):471-8. doi: 10.1038/onc.2012.66. Epub 2012 Mar 5.

16.

Classification of probe-based confocal laser endomicroscopy findings in pancreaticobiliary strictures.

Meining A, Shah RJ, Slivka A, Pleskow D, Chuttani R, Stevens PD, Becker V, Chen YK.

Endoscopy. 2012 Mar;44(3):251-7. doi: 10.1055/s-0031-1291545. Epub 2012 Jan 19.

PMID:
22261749
17.

Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.

Gonda TA, Glick MP, Sethi A, Poneros JM, Palmas W, Iqbal S, Gonzalez S, Nandula SV, Emond JC, Brown RS, Murty VV, Stevens PD.

Gastrointest Endosc. 2012 Jan;75(1):74-9. doi: 10.1016/j.gie.2011.08.022. Epub 2011 Nov 17.

PMID:
22100297
18.

PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.

Liu J, Stevens PD, Li X, Schmidt MD, Gao T.

Mol Cell Biol. 2011 Dec;31(24):4917-27. doi: 10.1128/MCB.05799-11. Epub 2011 Oct 10.

19.

Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos).

Chen YK, Parsi MA, Binmoeller KF, Hawes RH, Pleskow DK, Slivka A, Haluszka O, Petersen BT, Sherman S, Devière J, Meisner S, Stevens PD, Costamagna G, Ponchon T, Peetermans JA, Neuhaus H.

Gastrointest Endosc. 2011 Oct;74(4):805-14. doi: 10.1016/j.gie.2011.04.016. Epub 2011 Jul 18.

PMID:
21762903
20.

Fully covered self-expandable metal stents for benign esophageal disease: a multicenter retrospective case series of 31 patients.

Buscaglia JM, Ho S, Sethi A, Dimaio CJ, Nagula S, Stavropoulos SN, Gonda TA, Poneros JM, Stevens PD.

Gastrointest Endosc. 2011 Jul;74(1):207-11. doi: 10.1016/j.gie.2011.02.024. Epub 2011 May 6. No abstract available.

PMID:
21549373
21.

Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation.

Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, Capiak KM, Lightdale CJ, Abrams JA.

Dig Dis Sci. 2011 Jul;56(7):1996-2000. doi: 10.1007/s10620-011-1680-4. Epub 2011 Apr 6.

22.

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T, Evers BM.

Cancer Res. 2011 May 1;71(9):3246-56. doi: 10.1158/0008-5472.CAN-10-4058. Epub 2011 Mar 23.

23.

mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells.

Liu J, Stevens PD, Gao T.

J Biol Chem. 2011 Feb 25;286(8):6510-20. doi: 10.1074/jbc.M110.183087. Epub 2010 Dec 22.

24.

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H.

Clin Cancer Res. 2010 Oct 15;16(20):5028-37. doi: 10.1158/1078-0432.CCR-09-3209. Epub 2010 Sep 28.

25.

Prophylactic pancreatectomy for intraductal papillary mucinous neoplasm does not negatively impact quality of life: a preliminary study.

Lee MK, DiNorcia J, Pursell LJ, Holden MM, Tsai WY, Stevens PD, Goetz N, Grann VR, Chabot JA, Allendorf JD.

J Gastrointest Surg. 2010 Nov;14(11):1847-52. doi: 10.1007/s11605-010-1346-0. Epub 2010 Sep 8.

PMID:
20824365
26.

Diagnostic utility of chromosome 17 and p16 abnormalities in fluorescence in situ hybridization tests in primary sclerosing cholangitis.

Stein LL, Gonda TA, Stevens PD, Brown RS Jr.

Hepatology. 2010 Jul;52(1):393-4; author reply 394-5. doi: 10.1002/hep.23698. No abstract available.

PMID:
20583197
27.

Tuberous sclerosis complex 2 (TSC2) regulates cell migration and polarity through activation of CDC42 and RAC1.

Larson Y, Liu J, Stevens PD, Li X, Li J, Evers BM, Gao T.

J Biol Chem. 2010 Aug 6;285(32):24987-98. doi: 10.1074/jbc.M109.096917. Epub 2010 Jun 8.

28.

Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?

Iqbal S, Shah S, Dhar V, Stavropoulos SN, Stevens PD.

Dig Dis Sci. 2011 Jan;56(1):260-5. doi: 10.1007/s10620-010-1262-x. Epub 2010 May 13.

PMID:
20464492
29.

Cholangiopancreatoscopy for targeted biopsies of the bile and pancreatic ducts.

Iqbal S, Stevens PD.

Gastrointest Endosc Clin N Am. 2009 Oct;19(4):567-77. doi: 10.1016/j.giec.2009.06.005. Review.

PMID:
19917462
30.

Intraductal biliary and pancreatic endoscopy. Preface.

Stevens PD.

Gastrointest Endosc Clin N Am. 2009 Oct;19(4):xiii-xiv. doi: 10.1016/j.giec.2009.09.003. No abstract available.

PMID:
19917458
31.

Multimedia article: Transvaginal laparoscopic cholecystectomy: laparoscopically assisted.

Bessler M, Stevens PD, Milone L, Hogle NJ, Durak E, Fowler D.

Surg Endosc. 2008 Jul;22(7):1715-6. doi: 10.1007/s00464-008-9779-1. Epub 2008 Mar 6.

PMID:
18322746
32.

Transvaginal laparoscopically assisted endoscopic cholecystectomy: a hybrid approach to natural orifice surgery.

Bessler M, Stevens PD, Milone L, Parikh M, Fowler D.

Gastrointest Endosc. 2007 Dec;66(6):1243-5. Epub 2007 Sep 24. No abstract available.

PMID:
17892873
33.

Nonvariceal upper gastrointestinal bleeding.

DiMaio CJ, Stevens PD.

Gastrointest Endosc Clin N Am. 2007 Apr;17(2):253-72, v. Review.

PMID:
17556147
34.
35.
36.

Superparamagnetic nanoparticle-supported enzymatic resolution of racemic carboxylates.

Gardimalla HM, Mandal D, Stevens PD, Yen M, Gao Y.

Chem Commun (Camb). 2005 Sep 21;(35):4432-4. Epub 2005 Aug 11.

PMID:
16136241
37.

Superparamagnetic nanoparticle-supported catalysis of Suzuki cross-coupling reactions.

Stevens PD, Fan J, Gardimalla HM, Yen M, Gao Y.

Org Lett. 2005 May 26;7(11):2085-8.

PMID:
15901140
38.

Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic Cancer.

Frucht H, Stevens PD, Fogelman DR, Verna EC, Chen J, Chabot JA, Fine RL.

Curr Treat Options Gastroenterol. 2004 Oct;7(5):343-354.

PMID:
15345205
39.

EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study.

Larghi A, Verna EC, Stavropoulos SN, Rotterdam H, Lightdale CJ, Stevens PD.

Gastrointest Endosc. 2004 Feb;59(2):185-90.

PMID:
14745390
40.

Coding for EUS.

Stevens PD, Wiersema MJ.

Gastrointest Endosc. 2000 Dec;52(6 Suppl):S50-4. No abstract available.

PMID:
11115948
41.

A multicenter U.S. experience with EUS-guided fine-needle aspiration using the Olympus GF-UM30P echoendoscope: safety and effectiveness.

Sahai AV, Schembre D, Stevens PD, Chak A, Isenberg G, Lightdale CJ, Sivak MV Jr, Hawes RH.

Gastrointest Endosc. 1999 Dec;50(6):792-6.

PMID:
10570338
42.

Managing chronic pancreatitis pain: a block in time.

Stevens PD, Lightdale CJ.

Am J Gastroenterol. 1999 Apr;94(4):872-4. No abstract available.

PMID:
10201449
43.

The role of endosonography in the diagnosis and management of pancreatic cancer.

Stevens PD, Lightdale CJ.

Surg Oncol Clin N Am. 1998 Jan;7(1):125-33. Review.

PMID:
9443990
44.

Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption.

Siegel LM, Stevens PD, Lightdale CJ, Green PH, Goodman S, Garcia-Carrasquillo RJ, Rotterdam H.

Gastrointest Endosc. 1997 Sep;46(3):226-30.

PMID:
9378209
45.

Biliary stent replacement cytology.

Simsir A, Greenebaum E, Stevens PD, Abedi M.

Diagn Cytopathol. 1997 Mar;16(3):233-7.

PMID:
9099544
46.

Clinical applications of a new through-the-scope ultrasound probe: prospective comparison with an ultrasound endoscope.

Chak A, Canto M, Stevens PD, Lightdale CJ, Van de Mierop F, Cooper G, Pollack BJ, Sivak MV Jr.

Gastrointest Endosc. 1997 Mar;45(3):291-5. No abstract available.

PMID:
9087836
47.

Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula.

Kozarek RA, Raltz S, Brugge WR, Schapiro RH, Waxman I, Boyce HW, Baillie J, Branch MS, Stevens PD, Lightdale CJ, Lehman GA, Benjamin S, Fleischer DE, Axelrad A, Kortan P, Marcon N.

Gastrointest Endosc. 1996 Nov;44(5):562-7. Erratum in: Gastrointest Endosc 1996 Dec;44(6):764. Branch, S [corrected to Branch, MS]; Stevens, P [corrected to Stevens, PD].

PMID:
8934162
48.

Increased expression of the cyclin D1 gene in Barrett's esophagus.

Arber N, Lightdale C, Rotterdam H, Han KH, Sgambato A, Yap E, Ahsan H, Finegold J, Stevens PD, Green PH, Hibshoosh H, Neugut AI, Holt PR, Weinstein IB.

Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):457-9.

49.

Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus.

Stevens PD, Lightdale CJ, Green PH, Siegel LM, Garcia-Carrasquillo RJ, Rotterdam H.

Gastrointest Endosc. 1994 Nov-Dec;40(6):747-9. No abstract available.

PMID:
7859976
50.

Hypertensive emergency and ventricular tachycardia after endoscopic epinephrine injection of a Mallory-Weiss tear.

Stevens PD, Lebwohl O.

Gastrointest Endosc. 1994 Jan-Feb;40(1):77-8. No abstract available.

PMID:
8163143

Supplemental Content

Loading ...
Support Center